Actively Recruiting
Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia
Led by Peking University Third Hospital · Updated on 2024-07-22
47
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective cohort study to examine patients with borderline developmental dysplasia of the hip (BDDH) who have undergone hip arthroscopy for minimally invasive treatment of glenoid and labral injuries. The goal is to optimize surgical indications and improve surgical techniques to achieve accurate and rapid repair, rehabilitation, and functional recovery. This study aims to serve national fitness and treat patients' hip injuries effectively. The study builds on previous work by expanding the cohort size to analyze differences in outcomes between arthroscopic glenolabial repair alone and combined with soft tissue enhancement. Researchers seek to improve minimally invasive surgery methods to promote better efficacy for BDDH patients. No experimental drug or device intervention is involved, as it is an observational study. Participants will be followed over time with assessments conducted before surgery and 24 months after surgery. Key outcome measures include the Harris hip score, patient-reported outcome ratings, and cartilage damage grading using the Outerbridge classification. The study evaluates factors influencing surgical prognosis and aims to refine patient selection and treatment strategies for BDDH.
CONDITIONS
Brief Title
Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of borderline hip dysplasia with glenolabial injury
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to the day of surgery
Participants undergo assessments to evaluate hip dysplasia and associated cartilage damage before any treatment.
1 to 2 visits depending on assessments
Duration - 24 months after surgery
Participants are monitored over time to assess surgical prognosis and outcomes following arthroscopic treatment of hip dysplasia.
Periodic visits including assessments at preoperative and 24 months post-surgery
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital Medicial Science Research Ethics Committee
Beijing, China
Actively Recruiting
Research Team
J
Jianquan Wang, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here